RIVAROXABAN VIATRIS 15 mg + 20 mg, film-coated tablet 49 tablets
Active ingredients: Rivaroxaban
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet49 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RIVAROXABAN VIATRIS 15 mg + 20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes PVC PVDC aluminium de 49 comprimés (42 comprimés de 15 mg + 7 comprimés de 20 mg) - Kit d’initiation
- Marketing authorisation holder
- VIATRIS (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61711184CIP73026940CIP133400930269404Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIVAROXABANcomprimé 15 mg | 15 mg · un comprimé | SA |
| RIVAROXABANcomprimé 20 mg | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.